Sex and gender differences in the outcome of patients with COVID‐19.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is a new wave of emerging infections that the world is struggling with. Circulating ACE2 level can act as a contributing factor in determining the disease severity. it is recommended that more studies should be designed and implemented in the area of ACE2 role, protective or damaging, in pathogenesis and outcome of COVID-19 infection. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. [Extracted from the article]